Allergy & Asthma Network

We recently updated our  'Epinephrine Treatments’ and Anaphylaxis At a Glance' posters! Our 2024 updates include the addition of neffy, the new nasal spray epinephrine, on our treatments poster and the ‘Anaphylaxis at a Glance’ poster is your quick guide to recognizing and responding to life-threatening allergic reactions. Need an updated version? Check them out at our online store today! https://lnkd.in/d5-U52nk Thank you to ARS Pharmaceuticals, Inc. who has supported the 2024 updates. 

AstraZeneca and Amgen have announced positive results from their Phase III WAYPOINT trial for TEZSPIRE (tezepelumab), a new treatment for chronic rhinosinusitis with nasal polyps (CRSwNP). The study showed a significant reduction in nasal polyp size and improvement in nasal congestion. Learn more about this potential new treatment and how it may benefit patients: https://lnkd.in/eyvPPJxF

The USAsthma Summit 2024 was an incredible event! 🙌 It brought together healthcare professionals, educators, advocates, and community leaders from across the country to dive deep into asthma management, innovation, and health equity. 🌍💙 From powerful speakers to discussions, attendees walked away with tools and actionable strategies to make a lasting impact in their communities. We heard from experts tackling everything from asthma disparities to cutting-edge treatments—and even explored the unique respiratory challenges of different regions! 💬 "An excellent conference." 💬 "I learned a lot." Thank you to all the speakers, sponsors, and participants for making this event such a success! 🙏 Together, we’re working towards a future where everyone has access to the care and resources they need to breathe easier. 🌬️ Missed it? Stay tuned for updates on next year’s summit and how you can get involved! Thank you to our sponsors Amgen, AstraZeneca, Chiesi USA, Inc., GSK, Sanofi - Regeneron.

Ready to learn about the future of asthma treatment? 🫁✨ With new therapies like biologics, achieving remission is now a real goal for those living with asthma! Join us on November 12, 2024, at 12 PM ET for a deep dive into the “Remission of Asthma: Review of Consensus Statement.” We’ll explore updates from the American College of Allergy, Asthma and Immunology (ACAAI), American Academy of Allergy, Asthma and Immunology - AAAAI, and American Thoracic Society. Learn how asthma control is evolving and what this means for you or your patients! 🩺📊 👉 Register now: https://lnkd.in/exa2f8Qx #AsthmaRemission #AsthmaControl #Biologics #FreeWebinar #AllergyExperts #AsthmaCare #HealthInnovation This Advances webinar is in partnership with the American College of Allergy, Asthma and Immunology (ACAAI). ACAAI offers CMEs for physicians for this webinar. If you are a member of ACAAI, you can obtain CME through the member portal for Advances webinars.

🚨 New Chronic Urticaria in Skin of Color Podcast Episode Alert! 🎙️✨ How do hives appear on skin of color, and why is diagnosis often delayed? Join Kortney Kwong Hing and Dr. Payel Gupta, MD, FACAAI as Dr. Ama Alexis takes us through the unique challenges of managing urticaria in skin of color. This episode explores critical topics, from understanding diagnosis delays and the lack of educational resources for both patients and providers, to discussing if patients experience improved outcomes when their doctor reflects their background. Here’s what to expect: 📸 Identifying hives in darker skin tones  ⏳ Addressing diagnosis delays and treatment barriers  💼 Building partnerships with your healthcare provider  🌍 Expanding resources to better represent all skin tones Listen now on Spotify, Apple Podcasts, or wherever you get your podcasts! 💡 Want more? Don’t miss our comprehensive 6-part series on CSU! Episodes 75, 76, 77, 78, 80, & 82 Produced in collaboration with The Itch Podcast. Special thanks to Genentech for sponsoring this episode. All opinions on the show represent the views of the podcasters and the guest. Sponsorship does not influence content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement. #ChronicUrticaria #CU #Urticaria #Hives #SkinOfColor #ChronicHives #Podcast #HealthPodcast #Health 

Dr. Purvi Parikh, Allergy & Asthma Network national, advises families to stay vigilant with the recent rise in walking #pneumonia cases, especially among young children. “Seeing a doctor for the right diagnosis is essential for proper treatment,” she notes. Her advice? Regular hand washing, sneezing into sleeves, and keeping vaccinations updated to help curb the spread of infections. Check out the full segment from PIX11 News : https://lnkd.in/ez7mNvTF

According to The National Institutes of Health, American Indians/Alaska Natives are 20% more likely to have asthma than white Americans. Here at Allergy & Asthma Network, we are committed to supporting these communities by advancing better health through better understanding during #NativeAmericanHeritageMonth and beyond. Let’s Be the #SourceForBetterHealth this Native American Heritage Month for #AmericanIndian and #AlaskaNative communities and share trusted and reliable health information. Visit U.S. Department of Health and Human Services (HHS) Office of Minority Health to learn more about social determinants of health impacting AI/AN communities, access resources, health information, and more: https://lnkd.in/gA29u8zZ #NAHM #HealthEquity #AsthmaAwareness #IndigenousHealth #NAHM2024

✨ Navigating health insurance can feel overwhelming, but breaking it down into bite-sized steps can help! Elizabeth Johnson, from National Association of Medication Access & Patient Advocacy (NAMAPA), shares three key areas to focus on: 💸 Premium – How much you pay for your coverage 💰 Deductible – Your out-of-pocket costs 💊 Pharmacy Coverage – What you’ll pay for medications Once you understand these basics, you can dive into co-pays, coinsurance, and medication costs. 📲 Visit https://lnkd.in/e7HJGB6E for more tips and resources to make informed choices about your health insurance. And remember, if you’re struggling to afford your meds, reach out to your provider or patient assistance foundations for help! Thank you to Amgen for sponsoring this awareness campaign. #HealthInsurance #PatientAdvocacy #HealthCoverage #MedicationAccess

Last week, we held a webinar all about ‘Biologics: What They Are, How They Work, and Who Might Benefit’. Rajan Merchant, MD, FACAAI joined us for an informative webinar and in case you missed it, here are 5 key takeaways: 1️⃣Biologics are medicines that target parts of the immune system that cause inflammation. This helps treat conditions like asthma, eczema, and food allergies more directly. 2️⃣Many allergic diseases, like asthma and eczema, are linked to "Type 2 inflammation," driven by specific molecules. Biologics help by reducing this type of inflammation, which can prevent flare-ups and improve symptoms. 3️⃣Biologics allow for more personalized care, targeting specific molecules linked to each patient’s condition. This makes treatments more effective than general therapies. 4️⃣Biologics are now approved for different allergic conditions, like asthma, eczema, nasal polyps, eosinophilic esophagitis, and food allergies. They help reduce symptoms and the need for other medications. 5️⃣Biologics improve life for patients by lowering symptoms, reducing flare-ups, and keeping people out of the hospital. We also have the full recording and transcript available for your viewing at our website! https://lnkd.in/ejPuNCMb Special thanks to Sanofi/Regeneron who has provided funding support to make this webinar possible.

🚨 Happening Today! 🚨 Join us for Black People Like Me, our FREE virtual conference series focused on closing the health equity gap for Black communities with respiratory diseases. Today’s session covers COPD in the Black Community: risks, resources, and health equity. 🕓 4:30 PM ET – Don’t miss it! 💡 Learn about COPD diagnosis and management 👥 Hear personal stories 💬 Ask real-time questions to health experts Moderated by Catherine Blackwell, MBA, RN, Dr. Cedric "Jamie" Rutland MD FCCP and COPD patient, Misako Bonner. Register now: https://lnkd.in/eNA3HJyS Special thanks to Genentech and Viatris for their support of this awareness campaign.